Lyell Immunopharma, Inc. (LYEL)
22.46
+0.41
(+1.86%)
USD |
NASDAQ |
Mar 06, 16:00
22.23
-0.23
(-1.02%)
After-Hours: 20:00
Lyell Immunopharma SG&A Expense (TTM) : 49.04M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 701.17M |
| Nektar Therapeutics | 74.62M |
| GT Biopharma, Inc. | 4.731M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Vertex Pharmaceuticals, Inc. | 1.753B |